These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 12426668

  • 1. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
    Page ME, Brown K, Lucki I.
    Psychopharmacology (Berl); 2003 Jan; 165(2):194-201. PubMed ID: 12426668
    [Abstract] [Full Text] [Related]

  • 2. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
    Cryan JF, Page ME, Lucki I.
    Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
    Dekeyne A, Gobert A, Iob L, Cistarelli L, Melon C, Millan MJ.
    Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
    [Abstract] [Full Text] [Related]

  • 4. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
    Cryan JF, Page ME, Lucki I.
    Eur J Pharmacol; 2002 Feb 02; 436(3):197-205. PubMed ID: 11858799
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.
    Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC, Jones RM, Portoghese PS, Carlezon WA.
    J Pharmacol Exp Ther; 2003 Apr 02; 305(1):323-30. PubMed ID: 12649385
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
    Page ME, Lucki I.
    Neuropsychopharmacology; 2002 Aug 02; 27(2):237-47. PubMed ID: 12093597
    [Abstract] [Full Text] [Related]

  • 7. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test.
    Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I.
    Psychopharmacology (Berl); 1999 Nov 02; 147(2):162-7. PubMed ID: 10591883
    [Abstract] [Full Text] [Related]

  • 8. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters.
    Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J, Kong N, Smith JE, Davies HM, Dworkin SI.
    J Pharmacol Exp Ther; 1997 Aug 02; 282(2):727-33. PubMed ID: 9262336
    [Abstract] [Full Text] [Related]

  • 9. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.
    Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE.
    Eur J Pharmacol; 1999 Aug 27; 379(2-3):125-33. PubMed ID: 10497898
    [Abstract] [Full Text] [Related]

  • 10. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 11. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A, Kulkarni SK.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):177-85. PubMed ID: 17509558
    [Abstract] [Full Text] [Related]

  • 12. The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.
    Mizoguchi N, Saigusa T, Aono Y, Sekino R, Takada K, Oi Y, Ueda K, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):94-8. PubMed ID: 18996113
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z, Wróbel A, Krasicka-Domka M, Maj J.
    Pol J Pharmacol; 1999 Dec 28; 51(5):399-404. PubMed ID: 10817540
    [Abstract] [Full Text] [Related]

  • 14. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
    Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):482-95. PubMed ID: 17188790
    [Abstract] [Full Text] [Related]

  • 15. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
    Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA.
    J Pharmacol Exp Ther; 2001 Aug 30; 298(2):651-7. PubMed ID: 11454927
    [Abstract] [Full Text] [Related]

  • 16. Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats.
    Kocsis B, Li S, Hajos M.
    Hippocampus; 2007 Aug 30; 17(8):627-33. PubMed ID: 17492692
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice.
    Poleszak E, Wlaź P, Szewczyk B, Kedzierska E, Wyska E, Librowski T, Szymura-Oleksiak J, Fidecka S, Pilc A, Nowak G.
    Pharmacol Biochem Behav; 2005 Jul 30; 81(3):524-9. PubMed ID: 15936065
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM, Boules M, Zhang Y, Williams K, Robinson J, Carlier PR, Richelson E.
    Eur J Pharmacol; 2007 Jan 19; 555(1):30-6. PubMed ID: 17109850
    [Abstract] [Full Text] [Related]

  • 20. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW, Jiang WL, Zhong Y, Meng Q, Gai Y, Zhu HB, Hou J, Xing Y, Li YX.
    Neuroscience; 2011 Nov 24; 196():124-30. PubMed ID: 21925241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.